On Feb 02, 2026, RVTY reported earnings of 1.70 USD per share (EPS) for Q4 25, beating the estimate of 1.58 USD, resulting in a 7.45% surprise. Revenue reached 772.06 million, compared to an expected 776.51 million, with a -0.57% difference. The market reacted with a -1.57% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 17 analysts forecast an EPS of 1.05 USD, with revenue projected to reach 715.04 million USD, implying an decrease of -38.24% EPS, and decrease of -7.38% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
What were Revvity, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Revvity, Inc. reported EPS of $1.70, beating estimates by 7.45%, and revenue of $772.06M, -0.57% below expectations.
How did the market react to Revvity, Inc.'s Q4 2025 earnings?
The stock price moved down -1.57%, changed from $108.80 before the earnings release to $107.09 the day after.
When is Revvity, Inc. expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for Revvity, Inc.'s next earnings report?
Based on 17
analysts, Revvity, Inc. is expected to report EPS of $1.05 and revenue of $715.04M for Q1 2026.